Dr. Hetal Brahmbhatt is a Senior Manager, Science and Technology Team, Pharma Services, and Viral Vector Services at Thermo Fisher Scientific. She has a Ph.D. in Biochemistry and Biomedical Sciences from McMaster University where she characterized small molecule modulators of apoptotic proteins. In her previous role at Thermo Fisher Scientific (former Brammer Bio), she developed and established downstream purification processes for clinical manufacturing of several gene therapy viral vectors. In her present role, she contributes to the development of platform processes and technologies for the manufacturing of viral gene transfer vectors.

Talks

• PatheonTM Quick to ClinicTM: A Serotype Agnostic AAV Vector Manufacturing Platform